Sweden· SE-20201001000073
Clindamycin Abcur 150 mg/ml Injektions-/infusionsvätska, lösning
A medicinal product containing clindamycin, registered in Sweden by Abcur AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Clindamycin
- Manufacturer
- Abcur AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20201001000073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clindamycin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLINDAMYCIN HAMELNhameln pharma gmbh, Hameln
- FinlandClindamycin AbcurAbcur AB
- PolandClindamycin hamelnhameln Pharma GmbH
- BelgiumClindamycin Noridem 150 mg/mlNoridem Enterprises
- United StatesClindamycinMedical Purchasing Solutions, LLC
- SpainCLINDAMICINA KALCEKS 150 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFGKalceks As
- NorwayClindamycin AbcurAbcur AB
- United KingdomClindamycin 1% aqueous lotionPfizer Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Clindac, Clindamycin 1a Pharma
- Belgium · Clindamycin Noridem, Clindamycin Sandoz
- Bulgaria · Clindamycin Kabi, Далацин C
- Cyprus · Arfarel, Clindamycin Abr
- Czechia · Clindamycin Hameln, Clindamycin Kabi
- Germany · Clinda-Ipp, Clinda-Saar
- Denmark · Clindamycin Abcur, Clindamycin Alternova
- Estonia · Clindamycin Mip, Dalacin
- Spain · Clindamicina Aristo, Clindamicina Kalceks
- Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
- France · Clindamycine Kabi, Clindamycine Kalceks
- United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
- Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
- Croatia · Aknet, Dalacin
- Hungary · Clindamycin Anfarm, Clindamycin Hameln
- Ireland · Clindamycin, Clindamycin Kalceks
- Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
- Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
- Lithuania · Clindamycin Mip, Dalacin C
- Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
- Latvia · Clindamycin Kalceks, Clindamycin Mip
- Malta · Clidacin Ba Free Amp, Clindamicina Accord
- Netherlands · Clindamycin Teva, Clindamycine Added Pharma
- Norway · Clindamycin Abcur, Clindamycin Kalceks
- Poland · Clindacne, Clindalin
- Portugal · Clincina, Clindamicina Generis
- Romania · Clindamicină Hameln, Clindamycin Mip
- Slovenia · Dalacin, Klimicin
- Slovakia · Clindamycin Hameln, Clindamycin Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99301b3d-b4f2-4b9d-b520-92689264a7cf GET /v1/drugs/99301b3d-b4f2-4b9d-b520-92689264a7cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PAR",
"PL",
"sPAR"
],
"se_npl_id": "20201001000073",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20201001000073",
"product_doc_link": "https://docetp.mpa.se/LMF/Clindamycin%20Abcur%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee83037374.pdf"
}See everything about clindamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.